It was interesting to read about one immuno drug I believe that went to market in one of the articles
"The first vaccine to treat cancer, Provenge, was approved for some men with metastatic prostate cancer in 2010.
At the time, it was considered a major advance in cancer research. But the expensive product — which cost $93,000 for a course of treatment that improves patient survival by more than four months — didn’t sell as well as its then-owner, Dendreon, expected."
I did think when i saw the pyc immunology headline it was a nice use of statistics. Increased survivability by 100%. It didn't' actually cure by 100% just doubled life from 12 days to 24 days. I was curious why the mice were culled at this point, why not see how long they last and announce 200 or 300%?? Not sure how mouse life compares but 12 days to 24 days for some exorbitant price would not be a goer. Obviously even 4 months is not economically viable. If you are going to impress you need to clear tumors completely
PYC Price at posting:
4.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)